Of baseball and enhancement bondage
By Pete Shanks,
San Francisco Chronicle
| 09. 26. 2005
Baseball fans around the nation have been conducting their own straw poll about human enhancement, and they don't like it. Rafael Palmeiro has practically been driven out of the game, Mark McGwire is now seen as more cartoon than hero, and Jason Giambi is treated with widespread derision.
Then there is Barry Bonds.
Bonds is -- as usual -- a lightning rod for everyone's feelings, a walking paradox who illustrates without even trying just how complex these issues are. He told reporters before his first game in Washington, D.C., that there are more serious issues than steroids, but all that did was increase the hype about his appearance. And he lived up to it.
Bonds getting booed is not unusual in a road game. But in Washington, he was booed by fans who were on their feet as he homered to the upper deck -- clapping at the same time they were jeering. Whether they were right or wrong about Bonds (who denies ever knowingly taking illegal substances), there couldn't be a more dramatic illustration of the conflicts we feel...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...